Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D William Cameron

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Vaccine|November 16, 2004
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseClaire-Anne Siegrist, Maria Pihlgren, Chantal Tougne, et al.
The Journal of Infectious Diseases|June 11, 2008
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapyD William Cameron, Barbara A da Silva, Jose R Arribas, et al.
Chest|March 20, 2015
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in CanadaGonzalo G Alvarez, Deborah D Van Dyk, Marc Desjardlns, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse eventsAslam H Anis, Bohdan Nosyk, Huiying Sun, et al.
Frontiers in Immunology|October 26, 2019
Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in InfantsAgano Kiravu, Sophia Osawe, Anna-Ursula Happel, et al.
Plos One|April 13, 2011
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trialMark Holodniy, Sheldon T Brown, D William Cameron, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 9, 2011
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trialVilija R Joyce, Paul G Barnett, Adam Chow, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2021
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPDJuthaporn Cowan, Sunita Mulpuru, Sara J Abdallah, et al.
AIDS (London, England)|September 22, 2006
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral useGrace P S Kwong, Azra C Ghani, Richard A Rode, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 5, 2022
Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series designGonzalo G Alvarez, Kathryn Sullivan, Christopher Pease, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Vaccine|November 16, 2004
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseClaire-Anne Siegrist, Maria Pihlgren, Chantal Tougne, et al.
The Journal of Infectious Diseases|June 11, 2008
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapyD William Cameron, Barbara A da Silva, Jose R Arribas, et al.
Chest|March 20, 2015
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in CanadaGonzalo G Alvarez, Deborah D Van Dyk, Marc Desjardlns, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse eventsAslam H Anis, Bohdan Nosyk, Huiying Sun, et al.
Frontiers in Immunology|October 26, 2019
Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in InfantsAgano Kiravu, Sophia Osawe, Anna-Ursula Happel, et al.
Plos One|April 13, 2011
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trialMark Holodniy, Sheldon T Brown, D William Cameron, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 9, 2011
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trialVilija R Joyce, Paul G Barnett, Adam Chow, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2021
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPDJuthaporn Cowan, Sunita Mulpuru, Sara J Abdallah, et al.
AIDS (London, England)|September 22, 2006
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral useGrace P S Kwong, Azra C Ghani, Richard A Rode, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 5, 2022
Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series designGonzalo G Alvarez, Kathryn Sullivan, Christopher Pease, et al.
Pageof 10